{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:12:31Z","timestamp":1784261551526,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12020-016-0928-3","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T03:25:08Z","timestamp":1458617108000},"page":"259-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Acute liver damage following intravenous glucocorticoid treatment for Graves\u2019 ophthalmopathy"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-1615","authenticated-orcid":false,"given":"Mariacarla","family":"Moleti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Sturniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Campenn\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efisio","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Sisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vermiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"928_CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrendo.2009.61","volume":"5","author":"P Perros","year":"2009","unstructured":"P. Perros, G.E. Krassas, Graves\u2019 orbitopathy: a perspective. Nat. Rev. Endocrinol. 5, 312\u2013318 (2009)","journal-title":"Nat. Rev. Endocrinol."},{"key":"928_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"L. Bartalena, V. Fatourechi, Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J. Endocrinol. Invest. 37, 691\u2013700 (2014)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR3","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"E. Piantanida, M.L. Tanda, A. Lai, L. Sassi, L. Bartalena, Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J. Endocrinol. Invest. 36, 444\u2013449 (2013)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"F. Menconi, M.A. Profilo, M. Leo, E. Sisti, M.A. Altea, R. Rocchi, F. Latrofa, M. Nardi, P. Vitti, C. Marcocci, M. Marin\u00f2, Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: rundle\u2019s curve revisited. Thyroid 24, 60\u201366 (2014)","journal-title":"Thyroid"},{"key":"928_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ncpendmet0497","volume":"3","author":"WM Wiersinga","year":"2007","unstructured":"W.M. Wiersinga, Management of Graves\u2019 ophthalmopathy. Nat. Clin. Pract. Endocrinol. Metab. 3, 396\u2013404 (2007)","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"928_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"L. Bartalena, Diagnosis and management of Graves\u2019 disease: a global overview. Nat. Rev. Endocrinol. 9, 724\u2013734 (2013)","journal-title":"Nat. Rev. Endocrinol."},{"key":"928_CR7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Curr\u00f2, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marino, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid 18, 333\u2013346 (2008)","journal-title":"Thyroid"},{"key":"928_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"S Zang","year":"2011","unstructured":"S. Zang, K.A. Ponto, G.J. Kahaly, Clinical review: intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity. J. Clin. Endocrinol. Metab. 96, 320\u2013332 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40618-014-0227-x","volume":"38","author":"M Riedl","year":"2015","unstructured":"M. Riedl, E. Kolbe, E. Kampmann, I. Kramer, G.J. Kahaly, Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves\u2019 orbitopathy. J. Endocrinol. Invest. 38, 177\u2013182 (2015)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/ceo.12317","volume":"42","author":"G Gao","year":"2014","unstructured":"G. Gao, J. Dai, Y. Qian, F. Ma, Meta-analysis of methylprednisolone pulse therapy for Graves\u2019 ophthalmopathy. Clin. Exp. Ophthalmol. 42, 769\u2013777 (2014)","journal-title":"Clin. Exp. Ophthalmol."},{"key":"928_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/EJE-11-0779","volume":"166","author":"C Marcocci","year":"2012","unstructured":"C. Marcocci, T. Watt, M.A. Altea, A.K. Rasmussen, U. Feldt-Rasmussen, J. Orgiazzi, L. Bartalena, Fatal and non-fatal adverse events of glucocorticoid therapy for Graves\u2019 orbitopathy: a questionnaire survey among members of the European Thyroid Association. Eur. J. Endocrinol. 166, 247\u2013253 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"928_CR12","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"L Bartalena","year":"2012","unstructured":"L. Bartalena, G.E. Krassas, W. Wiersinga, C. Marcocci, M. Salvi, C. Daumerie, C. Bournaud, M. Stahl, L. Sassi, G. Veronesi, C. Azzolini, K.G. Boboridis, M.P. Mourits, M.R. Soeters, L. Baldeschi, M. Nardi, N. Curro, A. Boschi, M. Bernard, G. von Arx, Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy. J. Clin. Endocrinol. Metab. 97, 4454\u20134463 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/thy.2000.10.521","volume":"10","author":"M Weissel","year":"2000","unstructured":"M. Weissel, W. Hauff, Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 10, 521 (2000)","journal-title":"Thyroid"},{"key":"928_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/105072504774193276","volume":"14","author":"M Marino","year":"2004","unstructured":"M. Marino, E. Morabito, M.R. Brunetto, L. Bartalena, A. Pinchera, C. Marcocci, Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves\u2019 ophthalmopathy. Thyroid 14, 403\u2013406 (2004)","journal-title":"Thyroid"},{"key":"928_CR15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/1050725041692927","volume":"14","author":"M Salvi","year":"2004","unstructured":"M. Salvi, G. Vannucchi, F. Sbrozzi, A.B. Del Castello, A. Carnevali, S. Fargion, P. Beck-Peccoz, Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto\u2019s thyroiditis: case report. Thyroid 14, 631\u2013634 (2004)","journal-title":"Thyroid"},{"key":"928_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF03345386","volume":"28","author":"M Marino","year":"2005","unstructured":"M. Marino, E. Morabito, M.A. Altea, E. Ambrogini, F. Oliveri, M.R. Brunetto, L.E. Pollina, D. Campani, P. Vitti, L. Bartalena, A. Pinchera, C. Marcocci, Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves\u2019 ophthalmopathy treated successfully with glucocorticoids themselves. J. Endocrinol. Invest. 28, 280\u2013284 (2005)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR17","first-page":"180","volume":"16","author":"B Melamud","year":"2014","unstructured":"B. Melamud, Y. Lurie, E. Goldin, I. Levi, Y. Esayag, Methylprednisolone-induced liver injury: a diagnostic challenge. Isr. Med. Assoc. J. 16, 180\u2013181 (2014)","journal-title":"Isr. Med. Assoc. J."},{"key":"928_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-14-0712","volume":"172","author":"E Sisti","year":"2015","unstructured":"E. Sisti, B. Coco, F. Menconi, M. Leo, R. Rocchi, F. Latrofa, B. Mazzi, E. Albano, P. Vitti, C. Marcocci, M. Brunetto, M. Marino, Intravenous glucocorticoid therapy for Graves\u2019 ophthalmopathy and acute liver damage: an epidemiological study. Eur. J. Endocrinol. 172, 269\u2013276 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"928_CR19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Henegan","year":"2013","unstructured":"M.A. Henegan, A.D. Yeoman, S. Verma, A.D. Smith, M.S. Longhi, Autoimmune hepatitis. Lancet 382, 1433\u20131444 (2013)","journal-title":"Lancet"},{"key":"928_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0953-6205(02)00089-4","volume":"13","author":"GN Dalekos","year":"2002","unstructured":"G.N. Dalekos, K. Zachou, C. Liaskos, N. Gatselis, Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur. J. Intern. Med. 13, 293\u2013303 (2002)","journal-title":"Eur. J. Intern. Med."},{"key":"928_CR21","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1210\/jc.2013-3093","volume":"99","author":"M Moleti","year":"2014","unstructured":"M. Moleti, M.A. Violi, D. Montanini, C. Trombetta, B. Di Bella, G. Sturniolo, S. Presti, A. Alibrandi, A. Campenn\u00ec, S. Baldari, F. Trimarchi, F. Vermiglio, Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves\u2019 orbitopathy (GO): a prospective, randomized, single-blind clinical trial. J. Clin. Endocrinol. Metab. 99, 1783\u20131789 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40618-015-0255-1","volume":"38","author":"F Menconi","year":"2015","unstructured":"F. Menconi, M. Leo, P. Vitti, C. Marcocci, M. Marin\u00f2, Total thyroid ablation in Graves\u2019 orbitopathy. J. Endocrinol. Invest. 38, 809\u2013815 (2015)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40618-015-0257-z","volume":"38","author":"L Bartalena","year":"2015","unstructured":"L. Bartalena, P.E. Macchia, C. Marcocci, M. Salvi, F. Vermiglio, Effects of treatment modalities for Graves\u2019 hyperthyroidism on Graves\u2019 orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. J. Endocrinol. Invest. 38, 481\u2013487 (2015)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0168-8278(88)80517-8","volume":"7","author":"G Danan","year":"1988","unstructured":"G. Danan, Consensus meetings on: causality assessment of drug-induced liver injury. J. Hepatol. 7, 132\u2013136 (1988)","journal-title":"J. Hepatol."},{"key":"928_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajg.2014.131","volume":"109","author":"NP Chalasani","year":"2014","unstructured":"N.P. Chalasani, P.A. Hayashi, H.L. Bonkovsky, V.J. Navarro, W.M. Lee, R.J. Fontana, On behalf of the Practice Committee of the American College of Gastroenterology, ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induces liver injury. Am. J. Gastroenterol. 109, 1\u201317 (2014)","journal-title":"Am. J. Gastroenterol."},{"key":"928_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/WNF.0b013e3181bbf3a7","volume":"33","author":"A Loraschi","year":"2010","unstructured":"A. Loraschi, P. Banfi, M. Mauri, F. Sessa, G. Bono, M. Cosentino, Hepatotoxicity after high-dose methylprednisolone for demyelinating disease. Clin. Neuropharm. 33, 52\u201354 (2010)","journal-title":"Clin. Neuropharm."},{"key":"928_CR27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5812\/kowsar.1735143X.641","volume":"11","author":"K Gutkowski","year":"2011","unstructured":"K. Gutkowski, A. Chwist, M. Hartleb, Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat. Mon. 11, 656\u2013661 (2011)","journal-title":"Hepat. Mon."},{"key":"928_CR28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cld.2007.06.001","volume":"11","author":"BK Gunawan","year":"2011","unstructured":"B.K. Gunawan, N. Kaplowitz, 2007 Mechanisms of drug-induced liver disease. Clin. Liver Dis. 11, 459\u2013475 (2011)","journal-title":"Clin. Liver Dis."},{"key":"928_CR29","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/j.1572-0241.1999.03379.x","volume":"94","author":"T Nanki","year":"1999","unstructured":"T. Nanki, R. Koike, N. Miyasaka, Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. Am. J. Gastroenterol. 94, 3379 (1999)","journal-title":"Am. J. Gastroenterol."},{"key":"928_CR30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1572-0241.2002.05644.x","volume":"97","author":"SP Dourakis","year":"2002","unstructured":"S.P. Dourakis, V.A. Sevastianos, P. Kaliopi, Acute severe steatohepatitis related to prednisolone therapy. Am. J. Gastroenterol. 97, 1074\u20131075 (2002)","journal-title":"Am. J. Gastroenterol."},{"issue":"5 Suppl","key":"928_CR31","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","volume":"49","author":"JH Hoofnagle","year":"2009","unstructured":"J.H. Hoofnagle, Reactivation of hepatitis B. Hepatology 49(5 Suppl), S156\u2013S165 (2009)","journal-title":"Hepatology"},{"key":"928_CR32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/thy.2010.0158","volume":"22","author":"H Wichary","year":"2011","unstructured":"H. Wichary, T. Gasinska, Methylprednisolone and hepatotoxicity in Graves\u2019 ophthalmopathy. Thyroid 22, 64\u201369 (2011)","journal-title":"Thyroid"},{"key":"928_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2012.2201.ed","volume":"22","author":"R Bahn","year":"2011","unstructured":"R. Bahn, 2012 High-Dose Intravenous Glucocorticoid Therapy for Graves\u2019 Ophthalmopathy: where Are We Now? Thyroid 22, 1\u20132 (2011)","journal-title":"Thyroid"},{"key":"928_CR34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10428190500521101","volume":"47","author":"A Shigematsu","year":"2006","unstructured":"A. Shigematsu, K. Okada, N. Abe, S. Ota, N. Kato, K. Kondo, S. Hige, J. Tanaka, M. Asaka, M. Imamura, Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone. Leuk. Lymphoma 47, 1397\u20131399 (2006)","journal-title":"Leuk. Lymphoma"},{"key":"928_CR35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2169\/internalmedicine.31.208","volume":"31","author":"Y Koga","year":"1992","unstructured":"Y. Koga, R. Kumashiro, K. Yasumoto, S. Shakado, N. Ono, H. Noguchi, K. Nagata, M. Sata, H. Abe, N. Kaku, K. Tanikawa, Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Intern. Med. 31, 208\u2013213 (1992)","journal-title":"Intern. Med."},{"key":"928_CR36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejim.2004.10.018","volume":"16","author":"HM Hofstee","year":"2005","unstructured":"H.M. Hofstee, P.W. Nanayakkara, C.D. Stehouwer, Acute hepatitis related to prednisolone. Eur. J. Intern. Med. 16, 209\u2013210 (2005)","journal-title":"Eur. J. Intern. Med."},{"key":"928_CR37","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3748\/wjg.14.5474","volume":"14","author":"A Takahashi","year":"2008","unstructured":"A. Takahashi, Y. Kanno, Y. Takahashi, N. Sakamoto, K. Monoe, H. Saito, K. Abe, J. Yokokawa, A. Irisawa, H. Ohira, Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J. Gastroenterol. 14, 5474\u20135477 (2008)","journal-title":"World J. Gastroenterol."},{"key":"928_CR38","first-page":"356","volume":"2","author":"R Reu\u03b2","year":"2007","unstructured":"R. Reu\u03b2, K. Retzlaff, S. Vogel, F.E. Franke, P. Oschmann, Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS. CEJMed 2, 356\u2013359 (2007)","journal-title":"CEJMed"},{"key":"928_CR39","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1345\/aph.1H171","volume":"40","author":"F Topal","year":"2006","unstructured":"F. Topal, E. Ozaslan, S. Akbulut, M. K\u00fc\u00e7\u00fckazman, O. Y\u00fcksel, E. Altiparmak, Methylprednisolone-induced toxic hepatitis. Ann. Pharmacother. 40, 1868\u20131871 (2006)","journal-title":"Ann. Pharmacother."},{"key":"928_CR40","first-page":"236","volume":"21","author":"R Gerolami","year":"1997","unstructured":"R. Gerolami, P. Mambrini, M. Barthet, M.J. Jean-Pastor, J. Salducci, J.C. Grimaud, Acute hepatitis caused by Solupred in a patient with Crohn disease. Gastroenterol. Clin. Biol. 21, 236\u2013237 (1997)","journal-title":"Gastroenterol. Clin. Biol."},{"key":"928_CR41","first-page":"720","volume":"100","author":"FM Rivero","year":"2008","unstructured":"F.M. Rivero, J.M. Riesco, V.F. Moreira, A. Moreno, S.R.A. Lopez, G. Arranz, D.A.L. Ruiz, Recurrent acute liver toxicity from intravenous methylprednisolone. Rev. Esp. Enferm. Dig. 100, 720\u2013723 (2008)","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"928_CR42","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1210\/jc.2014-4463","volume":"100","author":"D Covelli","year":"2015","unstructured":"D. Covelli, G. Vannucchi, I. Campi, N. Curr\u00f2, R. D\u2019Ambrosio, M. Maggioni, U. Gianelli, P. Beck-Peccoz, M. Salvi, Statins may increase the risk of liver dysfunction in patients treated with steroids for active Graves\u2019 orbitopathy. J. Clin. Endocrinol. Metab. 100, 1731\u20131737 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR43","doi-asserted-by":"crossref","first-page":"835979","DOI":"10.1155\/2015\/835979","volume":"2015","author":"H Eguchi","year":"2015","unstructured":"H. Eguchi, J. Tani, S. Hirao, M. Tsuruta, I. Tokubuchi, K. Yamada, M. Kasaoka, Y. Teshima, T. Kakuma, Y. Hiromatsu, Liver dysfunction associated with intravenous methylprednisolone pulse therapy in patients with Graves\u2019 orbitopathy. Int. J. Endocrinol. 2015, 835979 (2015)","journal-title":"Int. J. Endocrinol."},{"key":"928_CR44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","volume":"17","author":"R Moli Le","year":"2007","unstructured":"R. Le Moli, L. Baldeschi, P. Saeed, N. Regensburg, M.P. Mourits, W.M. Wiersinga, Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves\u2019 ophthalmopathy. Thyroid 17, 357\u2013362 (2007)","journal-title":"Thyroid"},{"key":"928_CR45","first-page":"3562","volume":"86","author":"C Marcocci","year":"2001","unstructured":"C. Marcocci, L. Bartalena, M.L. Tanda, L. Manetti, E. Dell\u2019Unto, R. Rocchi, G. Barbesino, B. Mazzi, M.P. Bartolomei, P. Lepri, F. Cartei, M. Nardi, A. Pinchera, Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves\u2019 ophthalmopathy: results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 86, 3562\u20133567 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03343835","volume":"24","author":"PE Macchia","year":"2001","unstructured":"P.E. Macchia, M. Bagattini, G. Lupoli, M. Vitale, G. Vitale, G. Fenzi, High-dose intravenous corticosteroid therapy for Graves\u2019 ophthalmopathy. J. Endocrinol. Invest. 24, 152\u2013158 (2001)","journal-title":"J. Endocrinol. Invest."},{"key":"928_CR47","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","volume":"90","author":"GJ Kahaly","year":"2005","unstructured":"G.J. Kahaly, S. Pitz, G. Hommel, M. Dittmar, Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves\u2019 orbitopathy. J. Clin. Endocrinol. Metab. 90, 5234\u20135240 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","volume":"61","author":"S Aktaran","year":"2007","unstructured":"S. Aktaran, E. Akarsu, I. Erba\u00f0ci, M. Araz, S. Okumu\u00fe, M. Kartal, Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves\u2019 ophthalmopathy. Int. J. Clin. Pract. 61, 45\u201351 (2007)","journal-title":"Int. J. Clin. Pract."},{"key":"928_CR49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2006-1800","volume":"92","author":"F Menconi","year":"2007","unstructured":"F. Menconi, M. Marino, A. Pinchera, R. Rocchi, B. Mazzi, M. Nardi, L. Bartalena, C. Marcocci, Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves\u2019 orbitopathy treated with intravenous glucocorticoids. J. Clin. Endocrinol. Metab. 92, 1653\u20131658 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-07-0558","volume":"158","author":"RJ Geest van","year":"2008","unstructured":"R.J. van Geest, I.V. Sasim, H.P. Koppeschaar, R. Kalmann, S.N. Stravers, W.R. Bijlsma, M.P. Mourits, Methylprednisolone pulse therapy for patients with moderately severe Graves\u2019 orbitopathy: a prospective, randomized, placebo-controlled study. Eur. J. Endocrinol. 158, 229\u2013237 (2008)","journal-title":"Eur. J. Endocrinol."},{"key":"928_CR51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1575-0922(09)70841-1","volume":"56","author":"R Sanchez-Ortiga","year":"2009","unstructured":"R. Sanchez-Ortiga, O. Moreno-Perez, V.G. Sanchez, N.A. Mendoza, M.M. Dot, R.A. Guerra, A.L. Macia, A.P. Alfonso, Treatment of Graves\u2019 ophthalmopathy with highdose intravenous methylprednisolone: a comparison of two dosing regimens. Endocrinol. Nutr. 56, 118\u2013122 (2009)","journal-title":"Endocrinol. Nutr."},{"key":"928_CR52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF03401336","volume":"13","author":"BN Beleslin","year":"2014","unstructured":"B.N. Beleslin, J. Ciric, M. Zarkovic, M. Stojkovic, S. Savic, M. Knezevic, B. Stankovic, B. Trbojevic, B. Trbojevic, Efficacy and safety of combined parenteral and oral steroid therapy in Graves\u2019 orbitopathy. Hormones (Athens) 13, 222\u2013228 (2014)","journal-title":"Hormones (Athens)"},{"key":"928_CR53","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2013-3919","volume":"99","author":"W Zhu","year":"2014","unstructured":"W. Zhu, L. Ye, L. Shen, Q. Jiao, F. Huang, R. Han, X. Zhang, S. Wang, W. Wang, G. Ning, A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with Graves\u2019 ophthalmopathy. J. Clin. Endocrinol. Metab. 99, 1999\u20132007 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"928_CR54","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/thy.2015.0061","volume":"25","author":"E Sisti","year":"2015","unstructured":"E. Sisti, B. Coco, F. Menconi, M. Leo, R. Rocchi, F. Latrofa, M.A. Profilo, B. Mazzi, P. Vitti, C. Marcocci, M. Brunetto, M. Marin\u00f2, Age and dose are major risk factors for liver damage associated with intravenous glucocorticoid pulse therapy for Graves\u2019 orbitopathy. Thyroid 25, 846\u2013850 (2015)","journal-title":"Thyroid"},{"key":"928_CR55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/gut.2010.228478","volume":"60","author":"V Marco Di","year":"2011","unstructured":"V. Di Marco, V. Calvaruso, A. Iac\u00f2, F. Bronte, L. Biasi, K. Prestini, P. Sacchi, G. Amaddeo, G. Squadrito, R. Bruno, M. Puoti, A. Crax\u00ec, Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis. Gut 60, 1023 (2011)","journal-title":"Gut"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0928-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0928-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T17:01:10Z","timestamp":1567702870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0928-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0928-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}